INmune Bio Inc expected to post a loss of 63 cents a share - Earnings Preview

Inmune Bio

31/07/2024 24:43

* INmune Bio Inc  INMB.OQ   INMB.O  is expected to show a
fall in
quarterly revenue when it reports  results on August 1 for the
period ending January 1 0001
    * The Boca Raton Florida-based  company is expected to
report a
92.8% decrease in revenue to $3.33 thousand from $46 thousand a
year ago, according to the mean estimate from 3 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for INmune Bio Inc is for a
loss
of 63 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for INmune Bio
Inc is
$21.00​, above​ its last closing price of $8.26. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -0.53       -0.53      -0.61     Missed  -14
 Sep. 30 0001              -0.44      -0.47     Missed  -6.8
 Jan. 1 0001   -0.39       -0.39      -0.48     Missed  -21.5​
 Jan. 1 0001   -0.39       -0.40      -0.36     Beat    9.2
 ​​Jan.        -0.02       -0.02      -0.36     Missed  -1,700
 1 0001                                                 
 Jan. 1 0001   -0.47       -0.48      -0.32     Beat    18.1​
 Sep. 30 2022  -0.53       -0.52      -0.43     Beat    24.8
 Jan. 1 0001   -0.50       -0.50      -0.38     Beat    24.8
 This summary was machine generated July 30 at 23:43 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)